CCIA
Campbell & Co Investment Adviser’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $992K | Buy |
25,825
+15,135
| +142% | +$581K | 0.06% | 499 |
|
|
2025
Q1 | $414K | Buy |
+10,690
| New | +$414K | 0.03% | 758 |
|
|
2024
Q4 | – | Sell |
-125,236
| Closed | -$5.12M | – | 1169 |
|
|
2024
Q3 | $5.12M | Buy |
125,236
+39,394
| +46% | +$1.61M | 0.38% | 35 |
|
|
2024
Q2 | $3.3M | Buy |
+85,842
| New | +$3.3M | 0.28% | 68 |
|
|
2024
Q1 | – | Sell |
-13,231
| Closed | -$490K | – | 1220 |
|
|
2023
Q4 | $490K | Buy |
+13,231
| New | +$490K | 0.04% | 721 |
|
|
2023
Q3 | – | Sell |
-25,272
| Closed | -$901K | – | 1039 |
|
|
2023
Q2 | $901K | Sell |
25,272
-4,568
| -15% | -$163K | 0.16% | 191 |
|
|
2023
Q1 | $1.06M | Buy |
+29,840
| New | +$1.06M | 0.2% | 137 |
|
|
2022
Q4 | – | Sell |
-193,518
| Closed | -$5.7M | – | 864 |
|
|
2022
Q3 | $5.7M | Buy |
+193,518
| New | +$5.7M | 1.29% | 1 |
|
|
2020
Q4 | – | Sell |
-10,352
| Closed | -$390K | – | 470 |
|
|
2020
Q3 | $390K | Buy |
+10,352
| New | +$390K | 0.29% | 119 |
|
|
2019
Q1 | – | Sell |
-5,337
| Closed | -$226K | – | 549 |
|
|
2018
Q4 | $226K | Buy |
+5,337
| New | +$226K | 0.22% | 258 |
|
|
2013
Q3 | – | Sell |
-37,646
| Closed | -$1.88M | – | 293 |
|
|
2013
Q2 | $1.88M | Buy |
+37,646
| New | +$1.88M | 0.36% | 85 |
|